Amodei’s AI disease-cure forecast draws medical scrutiny
Anthropic CEO Dario Amodei said in an IPO roadshow video that properly applied AI could make cancer, Alzheimer’s disease, heart disease and mental illness history in under a decade. Medical and pharmaceutical experts cited by IT之家 and 36氪 questioned the timeline, noting that laboratory testing, animal studies, clinical trials and regulatory approval remain necessary; as of 2026, no AI-designed drug had reached broad clinical use.
Amodei’s forecast highlights AI’s claimed potential to accelerate biomedical research while underscoring the substantial validation still required before computational discoveries become approved treatments.

2026年11月10日,Anthropic CEO Dario Amodei在IPO路演里说,如果看癌症、阿尔茨海默病、心脏病和精神疾病,它们可能会在不到十年内成为“过去的遗物”。一种熟悉的科技叙事:AI又要“颠覆医疗”,模型再进步几代,疾病就会像旧软件里的Bug一样被修掉。但如果认真看Amodei从2024......
本文来自微信公众号: AIGC从0到1 ,作者:王零壹
2026年11月10日,Anthropic CEO Dario Amodei在IPO路演里说,如果看癌症、阿尔茨海默病、心脏病和精神疾病,它们可能会在不到十年内成为“过去的遗物”。
一种熟悉的科技叙事:AI又要“颠覆医疗”,模型再进步几代,疾病就会像旧软件里的Bug一样被修掉。
#Anthropic#Dario Amodei#AlphaFold#Demis Hassabis#Vertex Pharmaceuticals